No significant demographic or phenotypic differences were found between HLA-DQA1*05 carriers versus non-carriers, in either treatment group.
Alex McCarthy, PharmD
Advertisement
Articles by Alex McCarthy, PharmD
Advertisement
Latest Updated Articles
HLA-DQA1*05 Genotype Does Not Influence Clinical Response to Ustekinumab, VedolizumabPublished: November 29th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Two Doses of PCV20 in Lymphoma Survivors Elicits Greater Humoral Response
3
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials
4
Early Real-World Experience with VIMKUNYA Consistent with Clinical Trial Findings
5
